BLIS Technologies (NZSE:BLT) OCF Margin %: -1.73% (As of Mar. 2026)


What is BLIS Technologies OCF Margin %?

BLIS Technologies NZSE:BLT OCF Margin % is -1.73% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 958 Biotechnology companies, BLIS Technologies ranks better than 65.45% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. BLIS Technologies's Cash Flow from Operations for the six months ended in Mar. 2026 was NZ$-0.11 Mil. BLIS Technologies's Revenue for the six months ended in Mar. 2026 was NZ$6.23 Mil. Therefore, BLIS Technologies's OCF Margin % for the quarter that ended in Mar. 2026 was -1.73%.

As of today, BLIS Technologies's current OCF Yield % is -2.91%.

The historical rank and industry rank for BLIS Technologies's OCF Margin % or its related term are showing as below:

NZSE:BLT' s OCF Margin % Range Over the Past 10 Years
Min: -26.2   Med: 2.98   Max: 30.61
Current: -4.44

During the past 13 years, the highest OCF Margin % of BLIS Technologies was 30.61%. The lowest was -26.20%. And the median was 2.98%.

NZSE:BLT's OCF Margin % is ranked better than
65.45% of 958 companies
in the Biotechnology industry
Industry Median: -68.59 vs NZSE:BLT: -4.44

BLIS Technologies OCF Margin % Related Terms

BLIS Technologies OCF Margin % Historical Data

* Premium members only.

The historical data trend for BLIS Technologies's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BLIS Technologies OCF Margin % Chart

BLIS Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.20 1.07 10.06 15.52 -4.44

BLIS Technologies Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.64 13.32 17.57 -6.79 -1.73

NZSE:BLT vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, BLIS Technologies's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BLIS Technologies OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's OCF Margin % distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's OCF Margin % falls into.


BLIS Technologies OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

BLIS Technologies's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-0.595/13.404
=-4.44 %

BLIS Technologies's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.108/6.233
=-1.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -1.73% mean?
BLIS Technologies (NZSE:BLT) has a OCF Margin % of -1.73% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BLIS Technologies and its competitors. According to the industry distribution chart, BLIS Technologies ranks #331 out of 958 companies in the Biotechnology industry, placing it in the top 34.6%.
Is BLIS Technologies' OCF Margin % too high?
BLIS Technologies' current OCF Margin % is -1.73%. Based on the distribution chart, BLIS Technologies ranks #331 out of 958 companies in the Biotechnology industry, which is above the industry midpoint.
How does BLIS Technologies' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BLIS Technologies ranks #331 out of 958 companies for OCF Margin %. This puts BLIS Technologies in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BLIS Technologies and its competitors. BLIS Technologies's current OCF Margin % is -1.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BLIS Technologies stock overvalued right now?
Based on GuruFocus' analysis, BLIS Technologies (NZSE:BLT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$0.02, compared to a current price of NZ$0.02 — trading 20% below its estimated fair value. The current OCF Margin % is -1.73%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For BLIS Technologies (NZSE:BLT), the current OCF Margin % is -1.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BLIS Technologies Business Description

Address 399 Moray Place, Dunedin Central, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18, which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from North America. The company also generates a small portion of revenue from Non-core business, which includes grants and interest revenue.